'Exciting' cancer drug combination shrinks tumours and stops growth where other treatments failed, e
'Exciting' cancer drug combination shrinks tumours and stops growth where other treatments failed, early trial suggests
Chemotherapy cocktail could mean months longer life for people with advanced cancers
Alex Matthews-King Health Correspondent
4 hours ago
An exciting new cancer drug combination appears to shrink tumours and halt their growth for months, according to an early-stage clinical trial which could mean months of extra lfie for patients.
UK researchers have hailed the promising results from giving two chemotherapy drugs, vistusertib and paclitaxel, in tandem for late stage cancers which have become resistant to conventional treatments.
Though tests are in their early stages and set up to test safety rather than survival, the trial found over half of patients with ovarian cancer and 35 per cent of those with lung cancer saw their cancers shrink by at least a third.
The team, led by the Institute of Cancer Research in London and the Royal Marsden NHS Foundation Trust, also found the cocktail stopped tumours growing for an average of 5.8 months.
More:
https://www.independent.co.uk/news/health/cancer-chemotherapy-drug-combination-ovarian-lung-cancer-advanced-survival-life-expectancy-a8501811.html